Last $0.98 USD
Change Today -0.02 / -2.00%
Volume 23.4K
DYAI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard H. Jundzil

Vice President of Operations, Dyadic International, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

42$225,000
As of Fiscal Year 2013

Background*

Mr. Richard H. Jundzil has been a Vice President of Operations of Dyadic International, Inc. since May 2010. Mr. Jundzil Mr. Jundzil served as Dyadic's Director of Development & Quality since September 2008 and has held various laboratory, quality and regulatory positions of increasing responsibility since joining Dyadic in August 2003. In his new role, Mr. Jundzil continues to manage the production and distribution of Dyadic's enzyme products as well as its laboratories ...

Read Full Background

Corporate Headquarters*

140 Intracoastal Pointe Drive
Jupiter, Florida 33477

United States

Phone: 561-743-8333
Fax: 561-743-8343

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Boston University

Other Affiliations*

Annual Compensation*

Salary$200,000
Bonus$25,000
Total Annual Compensation$225,000

Stock Options*

Exercisable Options123,750
Unexercisable Options141,250
Total Number of Options265,000

Total Compensation*

Total Annual Cash Compensation$225,000
Total Short Term Compensation$225,000
Total Calculated Compensation$225,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAI:US $0.98 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Feike Sijbesma Chairman of Managing Board, Chief Executive Officer and Chairman of DSM Nutritional Products
Koninklijke DSM N.V.
€1.4M
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€5.4M
Richard Ridinger Chief Executive Officer
Lonza Group Ltd
--
Peder Holk Nielsen Chief Executive Officer and President
Novozymes A/S
kr8.3M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYADIC INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.